Tech Company Financing Transactions
Codetta Biosciences Funding Round
On 4/7/2022, Codetta Biosciences raised $15 million in Series A funding from Anzu Partners, Genoa Ventures and VC23.
Transaction Overview
Company Name
Announced On
4/7/2022
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors
Proceeds Purpose
Codetta will use the funds to accelerate the development of its multi-omic dsPCR platform and aggressively scale up its workforce in R&D, engineering, marketing, and business administration.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1800 Perimeter Park Drive
Morrisville, 27560
USA
Morrisville, 27560
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Developer of a multi-omics technology company intended to develop a quantitative and digital platform for nucleic acid and protein assays with unprecedented levels of sensitivity and simultaneous analyte detection. The company develops a unique digital spatial polymerase chain reaction and digital spatial Immuno polymerase chain reaction platform for multi-omic analysis from a single specimen, enabling researchers with greater insights from a single sample.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
TJ Johnson
Chief Marketing Officer
BJ Kerns
Chief Technical Officer
Tony Lemmo
Browse more venture capital transactions:
Prev: 4/7/2022: Lilt venture capital transaction
Next: 4/7/2022: Eleanor Health venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs